These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33614284)

  • 41. NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway.
    Liang J; Yun D; Jin W; Fan J; Wang X; Wang X; Li Y; Yu S; Zhang C; Li T; Yang X
    Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38587786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioinformatics analysis of LMAN1 expression, clinical characteristics, and its effects on cell proliferation and invasion in glioma.
    Du Q; Lin Y; Zhang W; He F; Xu Y; Chen Z
    Brain Res; 2022 Aug; 1789():147952. PubMed ID: 35623391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.
    Liu B; Liu Z; Wang Y; Lian X; Han Z; Cheng X; Zhu Y; Liu R; Zhao Y; Gao Y
    Mol Med; 2021 Sep; 27(1):117. PubMed ID: 34556022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trophinin-associated protein expression correlates with shorter survival of patients with glioma: a study based on multiple data fusion analysis.
    Sun Y; Liu ZD; Liu RZ; Lian XY; Cheng XB; Jia YL; Liu BF; Gao YZ; Wang X
    Mol Biol Rep; 2022 Aug; 49(8):7899-7909. PubMed ID: 35708862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of
    Huang SP; Chan YC; Huang SY; Lin YF
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High
    Wu Z; Wang D; Zeng F; Zhang Y; Zhu G; Ma Y; Song B; Lui S; Wu M
    Front Cell Dev Biol; 2021; 9():679684. PubMed ID: 34222249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptional Characteristics of
    Chang YZ; Li GZ; Pang B; Zhang KN; Zhang XH; Wang YZ; Jiang ZL; Chai RC
    Front Cell Dev Biol; 2020; 8():580464. PubMed ID: 33195221
    [No Abstract]   [Full Text] [Related]  

  • 50. Interfering with
    Gu S; Shu L; Zhou L; Wang Y; Xue H; Jin L; Xia Z; Dai X; Gao P; Cheng H
    Ann Transl Med; 2022 Dec; 10(23):1277. PubMed ID: 36618798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma.
    Tao BY; Liu YY; Liu HY; Zhang ZH; Guan YQ; Wang H; Shi Y; Zhang J
    Front Genet; 2022; 13():852049. PubMed ID: 35591854
    [No Abstract]   [Full Text] [Related]  

  • 52. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
    Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY
    Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-kB Pathway.
    Gao L; Wu J; Wang H; Yang Y; Zheng Z; Ni B; Wang X; Peng Y; Li Y
    Front Oncol; 2022; 12():770299. PubMed ID: 35280742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WZ-3146 acts as a novel small molecule inhibitor of KIF4A to inhibit glioma progression by inducing apoptosis.
    Yan T; Jiang Q; Ni G; Ma H; Meng Y; Kang G; Xu M; Peng F; Li H; Chen X; Wang M
    Cancer Cell Int; 2024 Jun; 24(1):221. PubMed ID: 38937742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC; Lo CM; Wang SH; Su EC
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
    Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
    Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma.
    Szeliga M
    Neurochem Int; 2022 Feb; 153():105256. PubMed ID: 34968631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.